Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest abdominal aortic aneurysm Stories

2010-06-07 12:04:00

BOSTON, June 7 /PRNewswire/ -- Patients with abdominal aortic aneurysms (AAAs) of less than 5.5 cm have no significant differences in clinical outcomes after endovascular repair (EVAR) than those with larger AAAs according to data from a five-year prospective clinical trial setting. The researchers maintain their recommendation that small aneurysms should not be treated surgically. Details of this study were presented at the 64th Vascular Annual Meeting presented by the Society for...

2010-06-04 08:00:00

IRVINE, Calif., June 4 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that TechAmerica has named Endologix as Orange County's Outstanding Company in Medical Technology. The award was presented to Endologix at the 17th Annual TechAmerica High-Tech Innovation Awards on June 2, 2010 in Irvine, CA. John McDermott, President and CEO, said, "It is an honor to receive this award from TechAmerica. It is a...

2010-06-01 15:30:00

IRVINE, Calif., June 1 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at the Jefferies 2010 Global Life Sciences Conference in New York, NY. Jefferies 2010 Global Life Sciences Event: Conference Date: Wednesday, June 9, 2010 Time:...

2010-05-21 08:00:00

IRVINE, Calif., May 21 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today that Thomas C. Wilder has joined the Endologix Board of Directors. Mr. Wilder was elected to the Board during the Company's 2010 Annual Meeting of Stockholders held on May 20, 2010. He replaces Paul McCormick, whose term on the Board expired at the Annual Meeting. With the addition of Mr. Wilder and the departure of Mr. McCormick,...

2010-05-19 16:15:00

CHICAGO, May 19 /PRNewswire/ -- Preoperative statin therapy has a protective effect on patients undergoing elective abdominal aortic aneurysm (AAA) repair that reduces risk and subsequent total hospital costs according to a new study from researchers at the East Carolina Heart Institute in Greenville, North Carolina. Published in the June issue of the Society of Vascular Surgery's®, Journal of Vascular Surgery®, this retrospective review compares 401...

2010-05-17 13:56:00

BOSTON, May 17 /PRNewswire/ -- The vascular surgeons at Massachusetts General Hospital (MGH) in Boston have traditionally repaired thoracoabdominal aortic aneurysms (TAA) with a clamp and sew (CS) technique that includes neuro-protective adjuncts like epidural cooling and aggressive intercostal reconstruction (IC) to prevent spinal cord ischemia. The last five years have seen a paradigm shift to distal aortic perfusion (DAP) during aortic cross clamping with the concurrent use of motor...

2010-05-11 06:45:00

Peripheral Vascular Device Market to Almost Double by 2016 VANCOUVER, May 11 /PRNewswire-FirstCall/ - According to a new report by iData Research (www.idataresearch.net), the leading authority in medical device and pharmaceutical market research, the U.S. peripheral vascular device market is worth $2.8 billion with expected growth to over $5.3 billion by 2016. Increased detection and treatment of abdominal aortic aneurysms (AAAs) and peripheral arterial disease (PAD) are the main drivers of...

2010-04-28 08:00:00

IRVINE, Calif., April 28 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today the publication of consolidated results from its prospective, multicenter clinical trials of the Company's Powerlink® stent graft for the endovascular repair of abdominal aortic aneurysms (AAA) using an anatomical fixation technique. The trial results demonstrate no aneurysm ruptures, no conversions to open...

2010-04-27 11:46:00

CHICAGO, April 27 /PRNewswire/ -- While repair of large abdominal aortic aneurysms (AAA's) is well accepted, randomized clinical trials have failed to demonstrate benefit for early surgical repair of small aneurysms over surveillance, according to researchers from New York-Presbyterian Hospital in New York. Details of their study appear in the May issue of the Journal of Vascular Surgery®, published by the Society for Vascular Surgery®. "Even though...

2010-04-15 08:00:00

IRVINE, Calif., April 15 /PRNewswire-FirstCall/ -- Endologix, Inc. (Nasdaq: ELGX), developer of minimally invasive treatments for aortic disorders, announced today details relating to the release of its first quarter 2010 financial results, which will take place on Thursday, April 22, 2010 after the close of the market. Endologix will hold a conference call on Thursday, April 22, 2010 at 5:00 p.m. ET / 2:00 p.m. PT to discuss the results. The dial-in numbers are (877) 407-0789 for domestic...